NORTHVILLE, Mich., July 29, 2015 /PRNewswire/ -- Gentherm (NASDAQ-GS:THRM), the global market leader and developer of innovative thermal management technologies, today announced its financial results for the second quarter and six months ended June 30, 2015.

For the 2015 second quarter and first six months, revenues increased to $213.4 million and $420.4 million, respectively, from $206.2 million and $400.1 million for the comparable prior year periods. Net income for this year's second quarter and first six months increased to $19.5 million and $39.3 million, respectively, from net income in the 2014 second quarter and first six months of $16.4 million and $33.0 million.

"We had a very busy and productive quarter, and we are seeing solid business activity and growth in all of our divisions around the world," said President and CEO Daniel R. Coker. "Our new business launches are also going well. Revenue in the first year we have owned our GPT (Gentherm Global Power Technologies) business is up about 54 percent, and based on the very strong early market testing of the new Atmos(TM) mattress, we expect the bed business to grow significantly during the second half of the year. We are growing revenues solidly in terms of local currencies in Europe, Canada and Asia, but the strength of the U.S. Dollar has impacted our revenue translated into U.S. Dollars by more than $25 million for the first half compared with the prior year. Fortunately, our costs are being affected favorably by exchange rate shifts so there has been no significant negative impact on profits from the revenue reduction."

"We are very pleased with our performance in terms of operations, keeping expenses in check and generating solid gross margins in the 30 percent range, and our earnings are right on target," Coker added. "All our core competencies are performing as planned. Our major headwind continues to be the strong U.S. Dollar, compared with local currencies, particularly the Euro, which has reduced our reported revenue but fortunately has not negatively impacted our earnings."

After the close of the quarter, the Company was awarded its first contract for its new battery thermal management system (BTM), a thermoelectric cooling system for batteries used in hybrid and electrified vehicles. The five-year contract, awarded by a major global automobile manufacturer, could generate up to $25 million in annual revenue with the first shipments to begin for model year 2017, Coker added.

"This is a very significant contract win for us because it opens up a brand new global market for Gentherm and enables us to leverage our thermal management technology and skills in an important new product category," Coker said. "As future vehicles become more and more electrified, their batteries need to be actively cooled to ensure a longer service life. The design created by our engineers has proven it can uniquely cool virtually any kind of battery packaging configuration used in vehicles in our target markets. We expect this to be a significant new growth opportunity for us that should increase as we work with more vehicle manufacturers and the hybrid and electrified vehicle markets expand."

Second Quarter Financial Highlights

For the 2015 second quarter, revenues were $213.4 million compared with $206.2 million in the prior year period. The revenue increase for the quarter was driven by continued strong shipments of the Company's Climate Control Seat (CCS(TM)) systems and a year-over-year increase of 54 percent in revenue to $12.5 million for GPT, which was acquired at the beginning of the second quarter of 2014 on April 1, 2014.

Foreign currency translation of the Company's Euro-denominated product revenue for this year's second quarter had a significant impact on the Company's product revenue results since the average U.S. Dollar/Euro exchange rate in this year's second quarter was 1.11 compared to 1.37 in the second quarter of 2014. Consequently, the Company's Euro dominated revenues, which have increased by 7 percent in Euros, have decreased in U.S. Dollar reported product revenues. The strong U.S. Dollar against certain other currencies had similar impacts on the Company's reported product revenues. Had the 2015 average exchange rate for this period been the same as the 2014 average exchange rate for these currencies, Gentherm's product revenues would have been $13.7 million higher than the revenues actually reported for the second quarter of 2015. Adjusting for this unfavorable currency translation impact, the second quarter 2015 product revenues would have been $227.1 million or 10 percent higher than the second quarter 2014, reflecting higher unit volumes in substantially all of the Company's markets and products.

CCS revenue in the 2015 second quarter, compared with the 2014 second quarter, increased by $10.1 million, or 12 percent, to $95.9 million. This increase resulted from new program launches since the first quarter 2014, strong production volumes and related sales of vehicles equipped with CCS systems, particularly vehicles in the luxury segment of the automotive market. One example of a new vehicle launch is the redesigned Ford Mustang, which now offers CCS for the first time.

Seat heater revenue in this year's second quarter decreased year-over-year by approximately $8.0 million, or 10 percent, to $74.1 million, reflecting the unfavorable impact of the declining Euro exchange rate. The Company's European denominated sales consist primarily of its seat heater products, whereas its CCS sales in Europe are primarily denominated in U.S. Dollars. Therefore, the unfavorable impact of the lower Euro translation rate is focused primarily on the Company's seat heater product sales. Adjusted for the decline in the value of the Euro, seat heater sales actually increased due to market penetration on certain vehicle programs and stronger vehicle production volumes, including those in Europe. Gentherm also had significant sales growth of its steering wheel heater product, which increased by $1.3 million, or 15 percent year over year, to $10.3 million.

Net income for the 2015 second quarter was up 19 percent year over year to $19.5 million or $0.54 per basic share and $0.53 per diluted share. Net income for the second quarter of 2014 was $16.4 million, or $0.46 per basic and diluted share.

Gross margin as a percentage of revenue for this year's second quarter increased to 30.8 percent, up from 29.5 percent for the 2014 second quarter. The increase was due to a favorable change in product mix, greater coverage of fixed costs at the higher volume levels, and a benefit from foreign currency impact on production expenses in foreign currencies. The favorable product mix was primarily attributable to the greater sales growth in CCS products on which Gentherm has historically had better margin performance. The stronger U.S. Dollar during the quarter resulted in lower production costs totaling $4.3 million.

Adjusted EBITDA for the 2015 second quarter was $33.9 million, up $1.6 million or 5 percent, compared with Adjusted EBITDA of $32.3 million for the 2014 second quarter.

Year-to-Date Summary

For the first six months of 2015, revenues increased to $420.4 million from $400.1 million in the first six months of 2014. CCS revenue increased year over year in the first six months of 2015 by $22.2 million, or 13 percent, to $190.3 million. Seat heater revenue decreased year over year by $15.6 million, or 10 percent, to $147.9 million. The Company also had significant growth in its heated steering wheel heater product with a year-over-year increase of $2.3 million, or 13 percent, to $20.0 million.

The average U.S. Dollar/Euro exchange rate for the first six months of this year was 1.12 compared with 1.37 for the first six months of the prior year. Consequently, the Company's Euro dominated revenues, which have increased by 7 percent in Euros, decreased in U.S. Dollar reported product revenues. The strong U.S. Dollar against certain other currencies had similar impacts on the Company's reported product revenues. Had the 2015 average exchange rate for this period been the same as the 2014 average exchange rate for these currencies, product revenues would have been $25.3 million higher than the revenues actually reported for the first half of 2015. Adjusting for this unfavorable currency translation impact, first half 2015 product revenues would have been $445.7 million or 11 percent higher than the first half 2014, reflecting higher unit volumes in substantially all of the Company's markets and products.

Net income for the first six months of 2015 was up 19 percent year over year to $39.3 million, or $1.10 per basic share and $1.08 per diluted share. Net income for the first six months of 2014 was $33.0 million, or $0.94 per basic share and $0.92 per diluted share, which included $1.1 million in fees and expenses associated with the acquisition of Global Thermoelectric Inc.

Further non-cash purchase accounting impacts associated with the recent acquisitions are detailed in the Acquisition Transaction Expenses, Purchase Accounting Impacts and Other Effects table accompanying the release.

Gross margin as a percentage of revenue for first six months of 2015 was 31.5 percent compared with 29.4 percent for the first six months of 2014.

Adjusted EBITDA for the first half of 2015 was $68.0 million compared with Adjusted EBITDA of $64.8 million for the comparable period of the prior year.

Guidance

The increase in the Company's revenues continues to be strong in local currencies. As Gentherm enters the second half of 2015, uncertain economic conditions in parts of Western and Eastern Europe and Asia are contributing to the increasing strength of the U.S. Dollar. This strengthening of the U.S. Dollar will continue to have an unfavorable impact on the Company's revenues in future periods. As a result, the Company now believes that 2015 revenue will be just below the low-end of the previous range of a 10 to 15 percent increase over 2014 revenue, which was $811 million.

Conference Call

As previously announced, Gentherm is conducting a conference call today to be broadcast live over the Internet at 5:00 PM Eastern Time to review these financial results. The dial-in number for the call is 1-877-407-4018 or 1-201-689-8471. The live webcast and archived replay of the call can be accessed in the Events page of the Investor section of Gentherm's website at www.gentherm.com.

About Gentherm

Gentherm (NASDAQ-GS: THRM) is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Automotive products include actively heated and cooled seat systems and cup holders, heated and ventilated seat systems, thermal storage bins, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), cable systems and other electronic devices. Non-automotive products include remote power generation systems, heated and cooled furniture and other consumer and industrial temperature control applications. The Company's advanced technology team is developing more efficient materials for thermoelectrics and new systems for waste heat recovery and electrical power generation. Gentherm has nearly ten thousand employees in facilities in the U.S., Germany, Canada, China, Hungary, Japan, Korea, Macedonia, Malta, Mexico, Ukraine and Vietnam. For more information, go to www.gentherm.com.

Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include statements regarding future sales, products, opportunities, markets, expenses and profits. Forward-looking statements involve known and unknown risks and uncertainties which may cause the Company's actual results in future periods to differ materially from forecasted results. Those risks include, but are not limited to, risks that sales may not increase, additional financing requirements may not be available, new competitors may arise, currency exchange rates may change, and adverse conditions in the industry in which the Company operates may negatively affect its results. Those and other risks are described in the Company's annual report on Form 10-K for the year ended December 31, 2014 and subsequent reports filed with the Securities and Exchange Commission (SEC), copies of which are available from the SEC or may be obtained from the Company. Except as required by law, the Company assumes no obligation to update the forward-looking statements, which are made as of the date hereof, even if new information becomes available in the future.

    Contact:                   Allen & Caron Inc

                               Mike Mason (investors)

                               michaelm@allencaron.com

                               (212) 691-8087

                               Rene Caron (investors)

                               rene@allencaron.com

                               Len Hall (media)

                               len@allencaron.com

                               (949) 474-4300

TABLES FOLLOW



                                                                                 GENTHERM INCORPORATED

                                                                      CONSOLIDATED CONDENSED STATEMENTS OF INCOME

                                                                         (In thousands, except per share data)

                                                                                      (Unaudited)


                                                   Three Months Ended                                           Six Months Ended
                                                      June 30,                                                June 30,
                                                      --------                                                --------

                                                2015                                2014                                   2015            2014

    Product revenues                                     $213,441                                         $206,182                     420,350             400,120

    Cost of sales                                       147,736                                          145,425                     288,075             282,338
                                                        -------                                          -------                     -------             -------

    Gross margin                                         65,705                                           60,757                     132,275             117,782

    Operating expenses:

    Net research and development expenses                14,977                                           14,550                      29,525              27,595

    Acquisition transaction expenses               -                                               -                             -              1,075

    Selling, general and administrative                  24,058                                           21,693                      49,003              39,560
                                                         ------                                           ------                      ------              ------

    Total operating expenses                             39,035                                           36,243                      78,528              68,230
                                                         ------                                           ------                      ------              ------

    Operating income                                     26,670                                           24,514                      53,747              49,552

    Interest expense                                      (544)                                           (970)                    (1,108)            (1,901)

    Revaluation of derivatives                             (53)                                           (340)                    (1,017)              (587)

    Foreign currency (loss) gain                          (107)                                           (320)                        328             (1,843)

    Gain from equity investment                    -                                               -                             -                785

    Other income (expense)                                  262                                               41                         457               (200)
                                                            ---                                              ---                         ---                ----

    Earnings before income tax                           26,228                                           22,925                      52,407              45,806

    Income tax expense                                    6,734                                            6,502                      13,093              12,804
                                                          -----                                            -----                      ------              ------

    Net income                                           19,494                                           16,423                      39,314              33,002

    Basic earnings per share                                $0.54                                            $0.46                       $1.10               $0.94
                                                            =====                                            =====                       =====               =====

    Diluted earnings per share                              $0.53                                            $0.46                       $1.08               $0.92
                                                            =====                                            =====                       =====               =====

    Weighted average number of shares - basic            35,971                                           35,361                      35,871              35,213
                                                         ======                                           ======                      ======              ======

    Weighted average number of shares - diluted          36,585                                           36,094                      36,429              35,841
                                                         ======                                           ======                      ======              ======



                                  GENTHERM INCORPORATED

                     RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME

                                (Unaudited, in thousands)


                                                  Three Months Ended          Six Months Ended

                                                    June 30,                   June 30,
                                                  --------               --------

                                                  2015              2014     2015              2014
                                                  ----              ----     ----              ----

    Net
     income                                    $19,494           $16,423  $39,314           $33,002

    Add Back:

        Income
        tax
        expense                                  6,734             6,502   13,093            12,804

        Interest
        expense                                    544               970    1,108             1,901

        Depreciation
        and
        amortization                             7,841             8,313   15,277            15,631

    Adjustments:

        Acquisition
        transaction
        expense                                      -                -       -            1,075

        Unrealized
        currency
        (gain)
        loss                                     (773)            (241)     100             1,024

        Unrealized
        revaluation
        of
        derivatives                                 53               340    (887)            (685)
                                                   ---               ---     ----              ----

     Adjusted
     EBITDA                                    $33,893           $32,307  $68,005           $64,752
                                               =======           =======  =======           =======

Use of Non-GAAP Financial Measures

In evaluating its business, Gentherm considers and uses Adjusted EBITDA as a supplemental measure of its operating performance. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, transaction expenses, debt retirement expenses, unrealized currency gain or loss and unrealized revaluation of derivatives. Management believes that Adjusted EBITDA is a meaningful measure of liquidity and the Company's ability to service debt because it provides a measure of cash available for such purposes. Management provides an Adjusted EBITDA measure so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis.

The term Adjusted EBITDA is not defined under GAAP, and is not a measure of operating income, operating performance or liquidity presented in accordance with GAAP. Adjusted EBITDA has limitations as an analytical tool, and when assessing the Company's operating performance, investors should not consider Adjusted EBITDA in isolation, or as a substitute for net income or other consolidated income statement data prepared in accordance with GAAP. Gentherm compensates for these limitations by relying primarily on its GAAP results and using Adjusted EBITDA only supplementally.




                                                                        GENTHERM INCORPORATED

                                           ACQUISITION TRANSACTION EXPENSES, PURCHASE ACCOUNTING IMPACTS AND OTHER EFFECTS

                                                         (Unaudited and in thousands, except per share data)


                                                                                                                           Three Months Ended Six Months Ended  Future Full Year Periods (estimated)

                                                                                                                                June 30,          June 30,
                                                                                                                                --------          --------

                                                                                                                                         2015              2014                                   2015       2014         2015         2016         2017   Thereafter
                                                                                                                                         ----              ----                                   ----       ----         ----         ----         ----   ----------


    Transaction related current expenses

    Acquisition transaction expenses                                                                                              $         -      $         -                           $         -    $1,075    $       -   $       -   $       -   $        -

    Non-cash purchase accounting impacts

    Customer relationships amortization                                                                                                $1,762            $2,173                                 $3,556     $4,229       $7,092       $7,092       $7,092       $24,470

    Technology amortization                                                                                                               758               934                                  1,531      1,796        3,051        3,051        2,188         2,086

    Product development costs amortization                                                                                                260               570                                  1,051      1,139        1,048           42            -            -

    Trade name amortization                                                                                                                46                52                                     93         52          183          183          137             -

    Order backlog amortization                                                                                                              -              410                                      -       410            -           -           -            -

    Inventory fair value adjustment                                                                                                         -            1,083                                      -     1,083            -           -           -            -
                                                                                                                                          ---            -----                                    ---     -----          ---         ---         ---          ---

                                                                                                                                       $2,826            $5,222                                 $6,231     $8,709      $11,374      $10,368       $9,417       $26,556

    Tax effect                                                                                                                          (658)          (1,241)                               (1,451)   (2,436)      (2,650)     (2,417)     (2,196)      (6,241)
                                                                                                                                         ----            ------                                 ------     ------       ------       ------       ------        ------

    Net income effect                                                                                                                  $2,168            $3,981                                 $4,780     $7,348       $8,724       $7,951       $7,221       $20,315
                                                                                                                                       ======            ======                                 ======     ======       ======       ======       ======       =======


    Earnings per share - difference

    Basic                                                                                                                               $0.06             $0.11                                  $0.13      $0.21

    Diluted                                                                                                                             $0.06             $0.11                                  $0.13      $0.21



                                                               GENTHERM INCORPORATED

                                                            CONSOLIDATED BALANCE SHEETS

                                                         (In thousands, except share data)

                                                                    (Unaudited)


                                                                           June 30,               December 31,
                                                                                2015                       2014
                                                                                ----                       ----

    ASSETS

    Current Assets:

    Cash and cash equivalents                                                            $101,643                   $85,700

    Accounts receivable, less allowance of $3,005 and $2,847,
     respectively                                                                       149,426                   136,183

    Inventory:

    Raw materials                                                                        49,559                    48,678

    Work in process                                                                       4,905                     4,009

    Finished goods                                                                       25,152                    24,956
                                                                                         ------                    ------

    Inventory, net                                                                       79,616                    77,643

    Derivative financial instruments                                                      2,195                       145

    Deferred income tax assets                                                            5,738                     6,247

    Prepaid expenses and other assets                                                    33,624                    29,107
                                                                                         ------                    ------

    Total current assets                                                                372,242                   335,025

    Property and equipment, net                                                         101,804                    91,727

    Goodwill                                                                             28,472                    30,398

    Other intangible assets                                                              56,916                    68,129

    Deferred financing costs                                                                356                       406

    Deferred income tax assets                                                           22,745                    18,843

    Derivative financial instruments                                                      5,094                     1,345

    Other non-current assets                                                             12,125                    12,019
                                                                                         ------                    ------

    Total assets                                                                         $599,754                  $557,892
                                                                                         ========                  ========

    LIABILITIES AND SHAREHOLDERS' EQUITY

    Current Liabilities:

    Accounts payable                                                                      $82,869                   $71,434

    Accrued liabilities                                                                  62,972                    68,387

    Current maturities of long-term debt                                                  4,505                     5,306

    Deferred tax liabilities                                                                 21                         -

    Derivative financial instruments                                                      5,296                     2,466

    Total current liabilities                                                           155,663                   147,593

    Pension benefit obligation                                                            9,867                    10,321

    Other liabilities                                                                     7,163                     2,788

    Long-term debt, less current maturities                                              81,078                    85,469

    Derivative financial instruments                                                      9,499                     6,698

    Deferred income tax liabilities                                                       9,636                    10,804
                                                                                          -----                    ------

    Total liabilities                                                                   272,906                   263,673

    Shareholders' equity:

    Common Stock:

    No par value; 55,000,000 shares authorized, 36,055,652 and
     35,696,334 issued and outstanding at June 30, 2015 and
     December 31, 2014, respectively                                                    249,661                   243,255

    Paid-in capital                                                                     (6,530)                  (8,224)

    Accumulated other comprehensive loss                                               (40,528)                 (25,743)

    Accumulated earnings                                                                124,245                    84,931
                                                                                        -------                    ------

    Total shareholders' equity                                                          326,848                   294,219
                                                                                        -------                   -------

    Total liabilities and shareholders' equity                                           $599,754                  $557,892
                                                                                         ========                  ========



                                                               GENTHERM INCORPORATED

                                                       CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                                   (In thousands)

                                                                    (Unaudited)


                                                                                Six Months Ended June 30,
                                                                              -------------------------

                                                                                 2015                     2014
                                                                                 ----                     ----

    Operating Activities:

    Net income                                                                             $39,314                        $33,002

    Adjustments to reconcile net income to cash provided by (used
     in) operating activities:

    Depreciation and amortization                                                         15,323                         15,931

    Deferred income tax benefit                                                          (4,765)                       (6,309)

    Stock compensation                                                                     2,983                          2,225

    Defined benefit plan expense                                                             105                             28

    Provision of doubtful accounts                                                           252                          (330)

    Gain on revaluation of financial derivatives                                           (150)                         (217)

    Gain from equity investment                                                     -                           (785)

    (Gain) loss on sale of property and equipment                                           (41)                            28

    Changes in operating assets and liabilities:

    Accounts receivable                                                                 (16,711)                      (17,456)

    Inventory                                                                            (4,433)                         5,024

    Prepaid expenses and other assets                                                    (6,674)                       (6,959)

    Accounts payable                                                                      13,148                        (1,312)

    Accrued liabilities                                                                    1,421                          1,496
                                                                                           -----                          -----

    Net cash provided by operating activities                                             39,772                         24,366

    Investing Activities:

    Investment in subsidiary, net of cash acquired                                          (47)                      (31,739)

    Proceeds from the sale of property and equipment                                         225                             44

    Purchases of property and equipment                                                 (23,029)                      (15,489)
                                                                                         -------                        -------

    Net cash used in investing activities                                               (22,851)                      (47,184)

    Financing Activities:

    Borrowing of debt                                                               -                          13,455

    Repayments of debt                                                                   (2,801)                      (12,470)

    Excess tax benefit from equity awards                                                  1,462                          4,155

    Cash paid for the cancellation of restricted stock                                     (467)                             -

    Proceeds from the exercise of Common Stock options                                     4,122                          3,406
                                                                                           -----                          -----

    Net cash provided by financing activities                                              2,316                          8,546
                                                                                           -----                          -----

    Foreign currency effect                                                              (3,294)                         2,541
                                                                                          ------                          -----

    Net increase (decrease) in cash and cash equivalents                                  15,943                       (11,731)

    Cash and cash equivalents at beginning of period                                      85,700                         54,885
                                                                                          ------                         ------

    Cash and cash equivalents at end of period                                            $101,643                        $43,154
                                                                                          ========                        =======

    Supplemental disclosure of cash flow information:

    Cash paid for taxes                                                                    $19,384                         $9,889
                                                                                           =======                         ======

    Cash paid for interest                                                                    $890                         $1,308
                                                                                              ====                         ======

    Supplemental disclosure of non-cash transactions:

    Common Stock issued to Board of Directors and
     employees                                                                              $1,389                         $1,330
                                                                                            ======                         ======

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/gentherm-reports-2015-second-quarter-and-six-month-results-300120692.html

SOURCE Gentherm